Featured Publications*
View All
New England Journal Of Medicine
Tepotinib in Non–Small Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Clinical Cancer Research
Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer.
JAMA Oncology
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.
Clinical Lung Cancer
Genomic Profiling of Advanced Non–Small Cell Lung Cancer in Community Settings: Gaps and Opportunities.
Journal of Clinical Oncology
Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA-Guided Therapy in Refractory Metastatic Solid Cancers: An Interim Analysis.
Case Studies
Advanced Breast Cancer
56-year-old female previously treated for early-stage breast cancer
Advanced CRC
63-year-old male referred to a large cancer center after metastases appeared
Advanced Lung Cancer
68-year-old male non-smoker who initially presented with severe cough and nausea

*Disclaimer: This content has not been reviewed by the FDA. Data shown for the performance of Guardant360® Laboratory Developed Test (LDT) does not convey the performance of Guardant360® CDx.

Learn about
FDA-approved Guardant360 CDx 
Learn about
Using Guardant360 CDx in your practice